vTv Therapeutics Inc. (NASDAQ: VTVT) went up by 13.01% from its latest closing price when compared to the 1-year high value of $6.09, while VTVT stocks collected +16.20% of gains with the last five trading sessions.
vTv Therapeutics Inc. (NASDAQ: VTVT) Worth an Investment?
vTv Therapeutics Inc. (NASDAQ: VTVT) The 36 Months beta value for VTVT stocks is at -3.63, while 1 of the analysts out of 1 who provided ratings for vTv Therapeutics Inc. stocks as a “buy” while 0 as overweight, 0 rated it as hold and 0 as sell. The average price we get from analysts is $8.00 which is $6.35 above current price. VTVT currently has a short float of 309.42% and public float of 483.54K with average trading volume of 564.35K shares.
VTVT Market Performance
VTVT stocks went up by 16.20% for the week, with the monthly jump of 23.13% and a quarterly performance of -32.65%, while its annual performance rate touched 1.85%. The simple moving average for the period of the last 20 days is 16.65% for VTVT stocks with the simple moving average of -14.68% for the last 200 days.
Analysts’ Opinion on vTv Therapeutics Inc. (NASDAQ: VTVT)
Many brokerage firms have already submitted their reports for VTVT stocks, with Stifel repeating the rating for VTVT shares by setting it to “Hold”. The predicted price for VTVT socks in the upcoming period according to Stifel is $1 based on the research report published on April 10, 2018.
ROTH Capital, on the other hand, stated in their research note that they expect to see VTVT stock at the price of $17. The rating they have provided for VTVT stocks is “Buy” according to the report published on March 8, 2018.
Northland Capital gave “Outperform” rating to VTVT stocks, setting the target price at $28 in the report published on February 8, 2018.
VTVT Stocks 0.50% Far from 50 Day Moving Average
After a stumble in the market that brought VTVT to its low price for the period of the last 52 weeks, vTv Therapeutics Inc. was unable to take a rebound, for now settling with -72.91% of loss for the given period.
The stock volatility was left at 9.18%, however, within the period of a single month, the volatility rate increased by 8.89%, while the shares surge at the distance of +25.00% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -23.26% lower at the present time.
In the course of the last 5 trading sessions, VTVT went up by +16.20%, which changed the moving average for the period of 200 days to the total of +35.25% of gains for the stock in comparison to the 20-day moving average settled at $1.43. In addition, vTv Therapeutics Inc. saw -37.74% in overturn over the period of a single year with a tendency to cut further losses.
VTVT Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at vTv Therapeutics Inc. (VTVT), starting from PERELMAN RONALD O, who bought 1,358,698 shares at the price of $1.84 back on May 15. After this action, Rushing now owns 17,852,351 shares of vTv Therapeutics Inc., valued at $2,500,004 with the latest closing price.
PERELMAN RONALD O, the 10% Owner of vTv Therapeutics Inc., bought 815,217 shares at the value of $1.84 during a trade that took place back on Feb 28, which means that PERELMAN RONALD O is holding 16,493,653 shares at the value of $1,499,999 based on the most recent closing price.
VTVT Stock Fundamentals
The current profitability levels are settled at -159.43 for the present operating margin. The net margin for vTv Therapeutics Inc. stands at -69.57. Equity return holds the value 18.10%, with -111.30% for asset returns.
The value for Enterprise to Sales is 4.30 with debt to enterprise value settled at 0.14. The receivables turnover for vTv Therapeutics Inc. is 3.11 with the total asset turnover at the value of 0.68. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.18.